Origami Therapeutics
Origami is discovering oral drugs to halt neurodegeneration. Their approach involves eliminating the toxic proteins that are the underlying cause of neurodegeneration using protein degraders to restore normal function. Origami’s discovery platform leverages our proprietary human disease models to select the drugs with
Origami Therapeutics is a business in neuro based in San Diego, CA, USA, founded in 2016.
Profile
Origami is discovering oral drugs to halt neurodegeneration. Their approach involves eliminating the toxic proteins that are the underlying cause of neurodegeneration using protein degraders to restore normal function. Origami’s discovery platform leverages our proprietary human disease models to select the drugs with the best chance of clinical success.
Its activity falls under neuro; the profile below is assembled from public directory data.
San Diego, CA, USA is where the company is located.
It is recorded at the Winter 2022 stage.
The company reports a headcount in the 4 range.
Total disclosed funding stands at about $5K.
| Sector | Neuro |
|---|---|
| Headquarters | San Diego, CA, USA |
| Country | USA |
| Founded | 2016 |
| Employees | 4 |
| Stage | Winter 2022 |
| Total funding | $499,988 |
Website: origamitherapeutics.com
Browse related
Create a free account